Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival

Stopped early · Phase 1

Conditions studied: Healthy

In brief

Feasibility trial to evaluate recovery and survival of red blood cells (RBCs) from Mirasol-treated whole blood

Key facts

Study ID

NCT00742001

Run by

Terumo BCTbio

People needed

12

Starts

2008-09-10

Expected to finish

2008-12-16

Last updated by the study team

2019-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy adults who meet AABB (formerly known as the American Association of Blood Banks) criteria for whole blood donation
• females incapable of becoming pregnant
• males agreeing to use contraception during trial

You may not qualify if…

• pregnancy or nursing
• abnormal medical history (bleeding disorders, anemia, myocardial ischemia, uncontrolled hypertension, heart disease, epilepsy)
• major surgery
• use of drugs affecting coagulation or RBC function
• recent participation in other trials which may confound results

Where it is running

• University of Cincinnati, Hoxworth Blood Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.